Portal de Periódicos da CAPES

THE PROSTATE SPECIFIC ANTIGEN ERA IN THE UNITED STATES IS OVER FOR PROSTATE CANCER: WHAT HAPPENED IN THE LAST 20 YEARS?

2004; Lippincott Williams & Wilkins; Volume: 172; Issue: 4 Part 1 Linguagem: Inglês

10.1097/01.ju.0000139993.51181.5d

1527-3792

Thomas A. Stamey, MITCHELL C. CALDWELL, John E. McNeal, Rosalie Nolley, Marci Hemenez, J. Downs,

Urologic and reproductive health conditions

No AccessJournal of UrologyAdult Urology: Oncology: Prostate/Testis/Penis/Urethra1 Oct 2004THE PROSTATE SPECIFIC ANTIGEN ERA IN THE UNITED STATES IS OVER FOR PROSTATE CANCER: WHAT HAPPENED IN THE LAST 20 YEARS?is corrected byRE: THE PROSTATE SPECIFIC ANTIGEN ERA IN THE UNITED STATES IS OVER FOR PROSTATE CANCER: WHAT HAPPENED IN THE LAST 20 YEARS?RE: THE PROSTATE SPECIFIC ANTIGEN ERA IN THE UNITED STATES IS OVER FOR PROSTATE CANCER: WHAT HAPPENED IN THE LAST 20 YEARS? THOMAS A. STAMEY, MITCHELL CALDWELL, JOHN E. McNEAL, ROSALIE NOLLEY, MARCI HEMENEZ, and JOSHUA DOWNS THOMAS A. STAMEYTHOMAS A. STAMEY More articles by this author , MITCHELL CALDWELLMITCHELL CALDWELL More articles by this author , JOHN E. McNEALJOHN E. McNEAL More articles by this author , ROSALIE NOLLEYROSALIE NOLLEY More articles by this author , MARCI HEMENEZMARCI HEMENEZ More articles by this author , and JOSHUA DOWNSJOSHUA DOWNS More articles by this author View All Author Informationhttps://doi.org/10.1097/01.ju.0000139993.51181.5dAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: We assessed how well preoperative serum prostate specific antigen (PSA) reflects the largest cancer in consecutive untreated radical prostatectomies during the last 20 years at Stanford University. Materials and Methods: A total of 1,317 consecutive radical prostatectomies were divided into 4, 5-year periods between August 1983 and July 2003, and examined sequentially in 3 mm step sections by 1 pathologist. The largest cancer and 5 other histological variables in each prostate were measured. Preoperative clinical stages were tabulated for each 5-year period. Means, Pearson correlation coefficients, % change and multiple regression were used to compare selected variables. Results: Most parameters decreased linearly during the 20 years, including palpable nodules on digital rectal examination from 91% to 17%, mean age from 64 to 59 years, mean serum PSA from 25 to 8 ng/ml, and index (largest) cancer volume from 5.3 to 2.4 cc. Percent Gleason grade 4/5 of the largest cancer averaged 27% to 35% and prostate weight 44 to 53 gm. Contrasting August 1983 to December 1988 with January 1999 to July 2003, 6 histological cancer parameters had statistically significant relationships to serum PSA in the first period. In the last 5 years serum PSA was related only to prostate size. Conclusions: Serum PSA was related to prostate cancer 20 years ago. In the last 5 years serum PSA has only been related to benign prostatic hyperplasia. There is an urgent need for serum markers that reflect the size and grade of this ubiquitous cancer. References 1 : Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med1987; 317: 909. Crossref, Medline, Google Scholar 2 : Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J Urol1989; 141: 1076. Link, Google Scholar 3 : Preoperative serum prostate-specific antigen (PSA) below 10 microg/l predicts neither the presence of prostate cancer nor the rate of postoperative PSA failure. Clin Chem2001; 47: 631. Crossref, Medline, Google Scholar 4 : Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml. J Urol2002; 167: 103. Link, Google Scholar 5 : Biological determinants of cancer progression in men with prostate cancer. JAMA1999; 281: 1395. Crossref, Medline, Google Scholar 6 : Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers. J Urol2000; 164: 1596. Link, Google Scholar 7 : Positive prostate biopsy rate consistently increases with age at the same prostate-specific antigen level in patients with normal digital rectal examination. Urology1998; 51: 531. Google Scholar 8 : Impact of age on total and complexed prostate-specific antigen cutoffs in a contemporary referral series of men with prostate cancer. Urology2002; 60: 47. Google Scholar 9 : Limitations of serum prostate specific antigen in predicting peripheral and transition zone cancer volume as measured by correlation coefficients. J Urol1996; 155: 232. Link, Google Scholar 10 : Patterns of spread of adenocarcinoma in the prostate as related to cancer volume. Prostate2001; 49: 48. Crossref, Medline, Google Scholar 11 : An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics. J Urol2000; 163: 1751. Link, Google Scholar 12 : Random systematic versus directed ultrasound-guided transrectal core-biopsies of the prostate. J Urol1989; 142: 71. Abstract, Google Scholar 13 : Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J Urol2003; 169: 125. Link, Google Scholar 14 : Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol2001; 166: 86. Link, Google Scholar 15 : SEER Cancer Statistics Review, 1975–2000. Bethesda: National Cancer Institute2003. http://seer.cancer.gov/csr/1975_2000. Google Scholar 16 : Age and racial distribution of prostatic intraepithelial neoplasia. Eur Urol1996; 30: 138. Crossref, Medline, Google Scholar 17 : On the frequency of occurrence of occult carcinoma of the prostate. J Urol1935; 33: 215. Link, Google Scholar 18 : Early detection of prostate cancer. Serendipity strikes again. JAMA1997; 278: 1516. Google Scholar 19 : Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. N Engl J Med2003; 349: 335. Google Scholar 20 : Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. J Urol2000; 163: 13. Link, Google Scholar From the Department of Urology, School of Medicine, Stanford University, Stanford, California© 2004 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited byBorges R, Tourinho-Barbosa R, Glina S, Macek P, Mombet A, Sanchez-Salas R and Cathelineau X (2020) Impact of Focal Versus Whole Gland Ablation for Prostate Cancer on Sexual Function and Urinary ContinenceJournal of Urology, VOL. 205, NO. 1, (129-136), Online publication date: 1-Jan-2021.Houston K, King J, Li J and Jemal A (2017) Trends in Prostate Cancer Incidence Rates and Prevalence of Prostate Specific Antigen Screening by Socioeconomic Status and Regions in the United States, 2004 to 2013Journal of Urology, VOL. 199, NO. 3, (676-682), Online publication date: 1-Mar-2018. (2016) Reply by AuthorsJournal of Urology, VOL. 197, NO. 1, (96-96), Online publication date: 1-Jan-2017.Marks L (2013) Editorial CommentJournal of Urology, VOL. 190, NO. 2, (501-501), Online publication date: 1-Aug-2013.Schade G, Keller J, Ives K, Cheng X, Rosol T, Keller E and Roberts W (2012) Histotripsy Focal Ablation of Implanted Prostate Tumor in an ACE-1 Canine Cancer ModelJournal of Urology, VOL. 188, NO. 5, (1957-1964), Online publication date: 1-Nov-2012.Ahmed H, Freeman A, Kirkham A, Sahu M, Scott R, Allen C, Van der Meulen J and Emberton M (2011) Focal Therapy for Localized Prostate Cancer: A Phase I/II TrialJournal of Urology, VOL. 185, NO. 4, (1246-1255), Online publication date: 1-Apr-2011.Juang H, Lin Y, Chang P and Tsui K (2010) Cardiac Glycosides Decrease Prostate Specific Antigen Expression by Down-Regulation of Prostate Derived Ets FactorJournal of Urology, VOL. 184, NO. 5, (2158-2164), Online publication date: 1-Nov-2010.Ouyang B, Bracken B, Burke B, Chung E, Liang J and Ho S (2009) A Duplex Quantitative Polymerase Chain Reaction Assay Based on Quantification of α-Methylacyl-CoA Racemase Transcripts and Prostate Cancer Antigen 3 in Urine Sediments Improved Diagnostic Accuracy for Prostate CancerJournal of Urology, VOL. 181, NO. 6, (2508-2514), Online publication date: 1-Jun-2009.Konety B (2008) Panning for Prostate Gold: Urine Based Markers for Prostate CancerJournal of Urology, VOL. 181, NO. 1, (9-10), Online publication date: 1-Jan-2009.Nguyen C, Reuther A, Stephenson A, Klein E and Jones J (2008) The Specific Definition of High Risk Prostate Cancer Has Minimal Impact on Biochemical Relapse-Free SurvivalJournal of Urology, VOL. 181, NO. 1, (75-80), Online publication date: 1-Jan-2009.Schostak M, Schwall G, Poznanović S, Groebe K, Müller M, Messinger D, Miller K, Krause H, Pelzer A, Horninger W, Klocker H, Hennenlotter J, Feyerabend S, Stenzl A and Schrattenholz A (2008) Annexin A3 in Urine: A Highly Specific Noninvasive Marker for Prostate Cancer Early DetectionJournal of Urology, VOL. 181, NO. 1, (343-353), Online publication date: 1-Jan-2009.Tan N, Lane B, Li J, Moussa A, Soriano M and Jones J (2008) Prostate Cancers Diagnosed at Repeat Biopsy are Smaller and Less Likely to be High GradeJournal of Urology, VOL. 180, NO. 4, (1325-1329), Online publication date: 1-Oct-2008.Thompson I, Tangen C, Ankerst D, Chi C, Lucia M, Goodman P, Parnes H and Coltman C (2008) The Performance of Prostate Specific Antigen for Predicting Prostate Cancer is Maintained After a Prior Negative Prostate BiopsyJournal of Urology, VOL. 180, NO. 2, (544-547), Online publication date: 1-Aug-2008.Kibel A (2008) Editorial CommentJournal of Urology, VOL. 179, NO. 5, (1784-1784), Online publication date: 1-May-2008.Nakanishi H, Groskopf J, Fritsche H, Bhadkamkar V, Blase A, Kumar S, Davis J, Troncoso P, Rittenhouse H and Babaian R (2008) PCA3 Molecular Urine Assay Correlates With Prostate Cancer Tumor Volume: Implication in Selecting Candidates for Active SurveillanceJournal of Urology, VOL. 179, NO. 5, (1804-1810), Online publication date: 1-May-2008.Halter R, Schned A, Heaney J, Hartov A, Schutz S and Paulsen K (2008) Electrical Impedance Spectroscopy of Benign and Malignant Prostatic TissuesJournal of Urology, VOL. 179, NO. 4, (1580-1586), Online publication date: 1-Apr-2008.Eggener S, Scardino P, Carroll P, Zelefsky M, Sartor O, Hricak H, Wheeler T, Fine S, Trachtenberg J, Rubin M, Ohori M, Kuroiwa K, Rossignol M and Abenhaim L (2007) Focal Therapy for Localized Prostate Cancer: A Critical Appraisal of Rationale and ModalitiesJournal of Urology, VOL. 178, NO. 6, (2260-2267), Online publication date: 1-Dec-2007.Flaig T, Nordeen S, Lucia M, Harrison G and Glodé L (2018) Conference Report and Review: Current Status of Biomarkers Potentially Associated With Prostate Cancer OutcomesJournal of Urology, VOL. 177, NO. 4, (1229-1237), Online publication date: 1-Apr-2007.Ochiai A, Troncoso P and Babaian R (2018) The Relationship Between Serum Prostate Specific Antigen Level and Tumor Volume Persists in the Current EraJournal of Urology, VOL. 177, NO. 3, (903-906), Online publication date: 1-Mar-2007.Ochiai A, Trpkov K, Yilmaz A, Donnelly B and Babaian R (2018) Validation of a Prediction Model for Low Volume/Low Grade Cancer: Application in Selecting Patients for Active SurveillanceJournal of Urology, VOL. 177, NO. 3, (907-910), Online publication date: 1-Mar-2007.Makarov D and Carter H (2018) The Discovery of Prostate Specific Antigen as a Biomarker for the Early Detection of Adenocarcinoma of the ProstateJournal of Urology, VOL. 176, NO. 6, (2383-2385), Online publication date: 1-Dec-2006.Kline E, Treat E, Averna T, Davis M, Smith A and Sillerud L (2018) Citrate Concentrations in Human Seminal Fluid and Expressed Prostatic Fluid Determined via 1H Nuclear Magnetic Resonance Spectroscopy Outperform Prostate Specific Antigen in Prostate Cancer DetectionJournal of Urology, VOL. 176, NO. 5, (2274-2279), Online publication date: 1-Nov-2006.Marks L, Andriole G, Fitzpatrick J, Schulman C and Roehrborn C (2018) The Interpretation of Serum Prostate Specific Antigen in Men Receiving 5α-Reductase Inhibitors: A Review and Clinical RecommendationsJournal of Urology, VOL. 176, NO. 3, (868-874), Online publication date: 1-Sep-2006.Porter C, Kodama K, Gibbons R, Correa R, Chun F, Perrotte P and Karakiewicz P (2018) 25-Year Prostate Cancer Control and Survival Outcomes: A 40-Year Radical Prostatectomy Single Institution SeriesJournal of Urology, VOL. 176, NO. 2, (569-574), Online publication date: 1-Aug-2006.Dyche D, Ness J, West M, Allareddy V and Konety B (2018) Prevalence of Prostate Specific Antigen Testing for Prostate Cancer in Elderly MenJournal of Urology, VOL. 175, NO. 6, (2078-2082), Online publication date: 1-Jun-2006.Mitchell R, Desai M, Shah J, Olsson C, Benson M and McKiernan J (2018) Preoperative Serum Prostate Specific Antigen Remains a Significant Prognostic Variable in Predicting Biochemical Failure After Radical ProstatectomyJournal of Urology, VOL. 175, NO. 5, (1663-1667), Online publication date: 1-May-2006.Nam R, Reeves J, Toi A, Dulude H, Trachtenberg J, Emami M, Daigneault L, Panchal C, Sugar L, Jewett M and Narod S (2018) A Novel Serum Marker, Total Prostate Secretory Protein of 94 Amino Acids, Improves Prostate Cancer Detection and Helps Identify High Grade Cancers at DiagnosisJournal of Urology, VOL. 175, NO. 4, (1291-1297), Online publication date: 1-Apr-2006.Kobayashi T, Mitsumori K, Kawahara T, Nishizawa K, Ogura K and Ide Y (2018) Prostate Cancer Detection Among Men With Prostate Specific Antigen Levels of 2.5 to 4.0 Ng/Ml in a Japanese Urological Referral PopulationJournal of Urology, VOL. 175, NO. 4, (1281-1285), Online publication date: 1-Apr-2006.Spurgeon S, Hsieh Y, Rivadinera A, Beer T, Mori M and Garzotto M (2018) Classification and Regression Tree Analysis for the Prediction of Aggressive Prostate Cancer on BiopsyJournal of Urology, VOL. 175, NO. 3, (918-922), Online publication date: 1-Mar-2006.Latchamsetty K, Kim J and Porter C (2018) Prostate Specific Antigen Remains an Independent Predictor of Cancer at Prostate Biopsy in Black American Men But Not in White Men: Results from a Consecutive Series of 914 MenJournal of Urology, VOL. 175, NO. 3, (913-917), Online publication date: 1-Mar-2006.Babaian R, Naya Y, Cheli C and Fritsche H (2018) The Detection and Potential Economic Value of Complexed Prostate Specific Antigen as a First Line TestJournal of Urology, VOL. 175, NO. 3, (897-901), Online publication date: 1-Mar-2006.Loeb S, Gonzalez C, Roehl K, Han M, Antenor J, Yap R and Catalona W (2018) Pathological Characteristics of Prostate Cancer Detected Through Prostate Specific Antigen Based ScreeningJournal of Urology, VOL. 175, NO. 3, (902-906), Online publication date: 1-Mar-2006.Nam R, Toi A, Trachtenberg J, Klotz L, Jewett M, Emami M, Sugar L, Sweet J, Pond G and Narod S (2018) Making Sense of Prostate Specific Antigen: Improving its Predictive Value in Patients Undergoing Prostate BiopsyJournal of Urology, VOL. 175, NO. 2, (489-494), Online publication date: 1-Feb-2006.NADLER R, LOEB S, ROEHL K, ANTENOR J, EGGENER S and CATALONA W (2018) USE OF 2.6 NG/ML PROSTATE SPECIFIC ANTIGEN PROMPT FOR BIOPSY IN MEN OLDER THAN 60 YEARSJournal of Urology, VOL. 174, NO. 6, (2154-2157), Online publication date: 1-Dec-2005.OCHIAI A, TRONCOSO P, CHEN M, LLORETA J and BABAIAN R (2018) THE RELATIONSHIP BETWEEN TUMOR VOLUME AND THE NUMBER OF POSITIVE CORES IN MEN UNDERGOING MULTISITE EXTENDED BIOPSY: IMPLICATION FOR EXPECTANT MANAGEMENTJournal of Urology, VOL. 174, NO. 6, (2164-2168), Online publication date: 1-Dec-2005.SENGUPTA S, MYERS R, SLEZAK J, BERGSTRALH E, ZINCKE H and BLUTE M (2018) PREOPERATIVE PROSTATE SPECIFIC ANTIGEN DOUBLING TIME AND VELOCITY ARE STRONG AND INDEPENDENT PREDICTORS OF OUTCOMES FOLLOWING RADICAL PROSTATECTOMYJournal of Urology, VOL. 174, NO. 6, (2191-2196), Online publication date: 1-Dec-2005.FREEDLAND S, MANGOLD L, WALSH P and PARTIN A (2018) THE PROSTATIC SPECIFIC ANTIGEN ERA IS ALIVE AND WELL: PROSTATIC SPECIFIC ANTIGEN AND BIOCHEMICAL PROGRESSION FOLLOWING RADICAL PROSTATECTOMYJournal of Urology, VOL. 174, NO. 4 Part 1, (1276-1281), Online publication date: 1-Oct-2005.Related articlesJournal of Urology9 Nov 2018RE: THE PROSTATE SPECIFIC ANTIGEN ERA IN THE UNITED STATES IS OVER FOR PROSTATE CANCER: WHAT HAPPENED IN THE LAST 20 YEARS?Journal of Urology9 Nov 2018RE: THE PROSTATE SPECIFIC ANTIGEN ERA IN THE UNITED STATES IS OVER FOR PROSTATE CANCER: WHAT HAPPENED IN THE LAST 20 YEARS? Volume 172Issue 4 Part 1October 2004Page: 1297-1301 Advertisement Copyright & Permissions© 2004 by American Urological Association, Inc.Keywordsprostate-specific antigenprostatic neoplasmsbiological markersprostatic hyperplasiaMetrics Author Information THOMAS A. STAMEY More articles by this author MITCHELL CALDWELL More articles by this author JOHN E. McNEAL More articles by this author ROSALIE NOLLEY More articles by this author MARCI HEMENEZ More articles by this author JOSHUA DOWNS More articles by this author Expand All Advertisement PDF downloadLoading ...